UrologiePub Date : 2025-09-01DOI: 10.1007/s00120-025-02657-8
{"title":"Abstracts des 77. Kongresses der Deutschen Gesellschaft für Urologie e. V.","authors":"","doi":"10.1007/s00120-025-02657-8","DOIUrl":"https://doi.org/10.1007/s00120-025-02657-8","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 Suppl 2","pages":"27-185"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-09-01Epub Date: 2025-08-18DOI: 10.1007/s00120-025-02659-6
Sophie Carina Kunte, Philipp M Kazmierczak, Adrien Holzgreve, Christian G Stief, Jozefina Casuscelli, Marcus Unterrainer, Lena M Unterrainer
{"title":"[Options in nuclear medicine for advanced prostate cancer in practice].","authors":"Sophie Carina Kunte, Philipp M Kazmierczak, Adrien Holzgreve, Christian G Stief, Jozefina Casuscelli, Marcus Unterrainer, Lena M Unterrainer","doi":"10.1007/s00120-025-02659-6","DOIUrl":"10.1007/s00120-025-02659-6","url":null,"abstract":"<p><p>Over the last few years diagnostic and therapeutic advances have contributed to the significant relevance of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and PSMA radioligand therapy in patients with advanced prostate cancer (PCa). The PSMA-PET/CT has a higher accuracy for the detection of PCa metastases than the combination of CT and bone scintigraphy. Based on the theranostic approach, PSMA radioligand therapy can be performed in the castration-resistant stage in patients with sufficient PSMA expression of the tumor lesions in PSMA PET/CT and progression of PCa after chemotherapy and therapy with abiraterone or an androgen receptor signalling pathway inhibitor. Over the next few years, a large number of studies on the effectiveness of PSMA radioligand therapy in earlier stages of PCa and as part of combination therapies with other drugs will be conducted.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"976-985"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144875559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-09-01Epub Date: 2025-07-15DOI: 10.1007/s00120-025-02639-w
Carolin C Hack, Katharina Seitz, Imke Thederan, Pia Wüfling, Bernd Wullich, Laura Bellut, Hans Joachim Herrmann, Yurdagül Zopf
{"title":"[Integration of complementary medicine in uro-oncology].","authors":"Carolin C Hack, Katharina Seitz, Imke Thederan, Pia Wüfling, Bernd Wullich, Laura Bellut, Hans Joachim Herrmann, Yurdagül Zopf","doi":"10.1007/s00120-025-02639-w","DOIUrl":"10.1007/s00120-025-02639-w","url":null,"abstract":"<p><strong>Background: </strong>The use of complementary medicine is growing in all fields of oncology.</p><p><strong>Objectives: </strong>This article aims to highlight the importance of integrating complementary medicine into uro-oncology.</p><p><strong>Methods: </strong>Based on current literature, an overview of the current state of complementary medicine and its importance in treatment management in uro-oncology is provided, as well as future opportunities and challenges.</p><p><strong>Results: </strong>Complementary medicine offers a valuable complement to conventional medicine in uro-oncology. While there is very good evidence for some procedures, which is reflected in the S3 guideline on complementary medicine for oncology patients, scientific evidence is lacking for others. Classic natural healing modalities, such as phytotherapy, hydrotherapy, nutrition, and exercise, can help improve patients' physical and psychological well-being, reduce complications and side effects, and achieve treatment goals.</p><p><strong>Conclusion: </strong>In recent years, complementary medicine has become established in oncology. It offers the opportunity to improve quality of life and treatment management, including in uro-oncology. It will continue to gain importance in the coming years.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"925-932"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144643692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-09-01Epub Date: 2025-07-09DOI: 10.1007/s00120-025-02642-1
K Kastrati, M Wartenberg
{"title":"[Shaping the future of oncology together : How genuine participation, more user focus, and partnership at eye level can change cancer medicine].","authors":"K Kastrati, M Wartenberg","doi":"10.1007/s00120-025-02642-1","DOIUrl":"10.1007/s00120-025-02642-1","url":null,"abstract":"<p><p>Oncology in Germany is on the brink of a necessary transformation: from self-help and occasional patient consultation toward genuine, structured patient involvement. Patients are not merely recipients of medical services but active users-with insights that can significantly improve research, care, digital innovation, and health policy. International examples show that co-creation is becoming the standard. Germany is also making initial progress, for instance, through the National Decade Against Cancer. What is needed now are nationwide structures, training, resources-and a mindset that recognizes patients as equal partners. In doing so, oncology can lead the way toward a new, participatory healthcare culture.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"917-924"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologiePub Date : 2025-09-01Epub Date: 2025-08-29DOI: 10.1007/s00120-025-02656-9
Susanne Landsmann
{"title":"[Selection process for scientific contribuions to the DGU Congress 2025].","authors":"Susanne Landsmann","doi":"10.1007/s00120-025-02656-9","DOIUrl":"https://doi.org/10.1007/s00120-025-02656-9","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 Suppl 2","pages":"25-26"},"PeriodicalIF":0.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144971897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}